The Metabolic effects of coenzyme Q10 in patients with Polycystic Ovary Syndrome

Abstract

There is a lack of evidence on the metabolic effect of coenzyme Q10 administration in women with polycystic ovary syndrome (PCOS). The present study aimed to investigate the influence of CoQ10 on glycemic control markers and lipid parameters in PCOS. The study employed a double-blind, placebo-controlled design. A total of 100 subjects with PCOS were enrolled. Subjects were randomly enrolled into 2 groups. The intervention group had received 200 mg CoQ10 supplements once daily (N = 50) and the control group had received corn starch (N = 50). The duration of treatment was three months for both groups. Fasting serum glucose, insulin levels and lipid parameters were recorded before and at the end of the study. After 3 months of intervention, patients whom receiving CoQ10 therapy (200mg/day) had significantly lower levels of fasting serum glucose, glycated hemoglobin, serum total cholesterol, low density lipoprotein cholesterol, and triglycerides were found between CoQ10-supplemented compared to placebo-treated women. Overall, three months of CoQ10 supplementation had a beneficial effect on glucose metabolism, lipid profile and atherogenic index in women with PCOS.